Oncologix Tech Inc.|4Jan 28, 7:17 AM ET

Kramarz Michael Anthony 4

4 · Oncologix Tech Inc. · Filed Jan 28, 2011

Form 4

Period: 2011-01-26

CFO

Transactions

Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$1.33/sh−45,000$59,850→ 210,000 total
Exercise: $1.33From: 2004-09-16Exp: 2012-09-16→ Common Stock (45,000 underlying)
Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.50/sh−30,000$15,000→ 170,000 total
Exercise: $0.50From: 2003-10-06Exp: 2013-10-06→ Common Stock (30,000 underlying)
Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.17/sh−20,000$3,300→ 100,000 total
Exercise: $0.17From: 2005-03-24Exp: 2015-03-24→ Common Stock (20,000 underlying)
Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.40/sh−100,000$40,000→ 0 total
Exercise: $0.40From: 2007-03-22Exp: 2013-03-22→ Common Stok (100,000 underlying)
Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.53/sh−10,000$5,300→ 200,000 total
Exercise: $0.53From: 2002-12-12Exp: 2012-12-12→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.23/sh−50,000$11,500→ 120,000 total
Exercise: $0.23From: 2004-07-15Exp: 2014-07-15→ Common Stock (50,000 underlying)
Award
Stock Options (Common Stock)
2011-01-26$0.03/sh+51,000$1,530→ 51,000 total
Exercise: $0.03From: 2011-01-07Exp: 2018-01-07→ Common Stock (51,000 underlying)

Footnotes (2)

[F1]On January 7, 2001, the Board of Directors of the Issuer determined that it would be in the best interest of the Company and its shareholders to reduce the number of authorized but unissued shares of common stock to outstanding stock purchase rights. If successfully accomplished, such reduction would serve to increase the number of shares available for the sale to finance the continuing operations of the Company. Accordingly, the board of Directors specifically authorized the exchange of presently outstanding rights to purchase 1,475,000 shares at prices between $0.165 and $1.33 for the rights to purchase up to 295,000 shares at a price of $0.03 per share. The transaction being reported on hereby reflects the acceptance by the filer of such exchange. The exchange was made on January 26, 2011.
[F2]Mr. Kramarz holds a direct interest in 51,000 stock options to purchase common stock.

Documents

1 file